Skip to main content
Tech.euFundingExplorerBeta

QV Bioelectronics

QV's GRACE implant will provide a paradigm shift in the treatment of glioblastoma (GBM), the most common form of primary brain cancer in adults that has amongst the worst outcomes of any type of cancer.

Total raised
€11M
€11,497,608
Funding rounds
6
Investors
19
distinct backers
Active since
2021-07
latest 2026-01

Funding by year

EUR raised per year · 2026 YTD

Signals

High confidence
Raise-next likelihood21
base rate 30% for Other
  • Raised very recently
  • Up-round momentum
  • Low backer re-investment
Exit likelihood16
base rate 12% (2+ rounds)
  • 6 rounds raised

Timing: too soon vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.